Faculty


Lisa A. Maier, M.D., M.S.P.H., F.C.C.P.
Assistant Professor of Medicine

EDUCATION/TRAINING

Cornell University, Ithaca, NY
1986 B.S. Food Science

Duke University, Durham, NC
1991 M.D.
1991-1994 Intern & Resident Internal Medicine

University of Colorado School of Medicine, Denver, CO
1998 M.S.P.H. Preventive Medicine

Duke University Medical Center, Durham, NC
1991-1994 Resident Internal Medicine
1993 Assistant Chief Resident Internal Medicine

University of Colorado School of Medicine, Denver, CO
1994-1998 Fellow Pulmonary/Critical Care

National Jewish Medical and Research Center &
University of Colorado School of Medicine, Denver, CO
1995-1998 Resident Occupational and Environmental Medicine


UCD
4200 E. Ninth Ave.
Denver, CO 80262
Tel: 303.398.1826
maierl@njc.org

Peer Reviewed Publications (selected from 15)

  1. Bovbjerg D, Redd W, Maier L, Holland J, Lesko L, Niedzwieki D, Rubin S, Hakes T. Anticipatory immune suppression in women receiving cyclic chemotherapy for ovarian cancer. J Clin Consult Psych 1990; 58:153-157.
  2. Maier L, Xu F, Hester S, Boyer C, McKenzie S, Bruskin A, Argon Y, Bast RC, Jr. Requirements for the internalization of the murine monoclonal antibody directed against the Her-2/neu gene product. Cancer Res 1991; 51:5361-5369.
  3. Crews J, Maier L, Yu Y, Hester S, O'Briant K, Leslie D, DeSombre K, George S, Boyer C, Argon Y, Bast RC, Jr. A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast cancer cell lines. Int J Cancer 1992; 51:772-779.
  4. Bast RC, Jr., Xu F, Yu Y, Crews J. Argon Y, Maier L, Lidor Y. Berchuck A, Boyer CM. Additive and synergistic interactions of monoclonal antibodies and immunotoxins reactive with breast and ovarian cancer (review). Immunol Series 1994; 61:23-30.
  5. Newman LS, Rose CS, Maier L. Medical progress: Sarcoidosis. N Engl J Med 1997; 336:1224-1234.
  6. Maier L, Raynolds MV, Young DA, Barker EA, Newman LS. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med 1999; 159:1342-1350.
  7. Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier L, Marrone BL. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and –DPA1 alleles. J Immunol 1999; 163(3):1647-53.
  8. Martyny JW, Hoover MD, Ellis K, Mroz MM, Bucher Bartelson B, Maier L, Newman LS. Characterization of beryllium aerosols generated during machining operations. J Occup Environ Med 2000; 42:8-18.
  9. Farris GM, Newman LS, Frome EL, Shou Y, Barker E, Habbersett RC, Maier L, Marrone BL. Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the immuno-BeLPT. Toxicology 2000; 143:125-140.
  10. Sawyer RT, Fadok VA, Kittle LA, Maier L and Newman LS. Beryllium-stimulated apoptosis in macrophage cell lines . Toxicology 2000; 149:129-142.
  11. Newman LS, Mroz MM, Maier L, Daniloff EM, Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. Journal of Occupational and Environmental Medicine 2001; 43:231-237.
  12. Kelleher PC, Martyny JW, Mroz MM, Maier L, Ruttenber JA, Young DA, Newman LS. Beryllium particulate exposure and disease relations in a beryllium machining plant. Journal of Occupational and Environmental Medicine 2001; 43:238-249.
  13. Maier LA, Sawyer RT, Tinkle SS, Barker EA, Balkissoon, Rose C, Newman LS. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis. Eur Respir J 2001; 17:403-415.
  14. Maier LA. Beryllium health effects in the era of the beryllium lymphocyte proliferation test. Appl Occup Environ Hyg 2001; 16(5): 514-520.
  15. Duong TX, Suruda AJ, Maier LA. Interstitial fibrosis following hydrogen sulfide exposure. Am J Ind Med 2000; 40:221-224.
  16. Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, Marrone BL. Beryllium sensitivity is linked to HLA-DP genotype. Toxicology; 165:27-38.
  17. Maier LA, Sawyer RT, Bauer RA, Kittle LA, Lympany P, McGrath D, duBois R, Daniloff E, Rose CS, and Newman LS. High beryllium-stimulated TNF-a is associated with the –308 TNF–a promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med (in press).
  18. Lundgren RA, Maier LA, Rose CS, Balkissoon RC, Newman LS. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest (in press).